In the name of ventilator-associated pneumonia prevention: lung microbiota blown away by colistin!

Nseir Saad, Martin-Loeches Ignacio

Source: Eur Respir J 2015; 46: 1544-1547
Journal Issue: December
Disease area: Respiratory critical care

Full text journal articlePDF journal article, handout or slides

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
Nseir Saad, Martin-Loeches Ignacio. In the name of ventilator-associated pneumonia prevention: lung microbiota blown away by colistin!. Eur Respir J 2015; 46: 1544-1547

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Ventilator-associated pneumonia due to colistin susceptible-only microorganisms
Source: Eur Respir J 2007; 30: 307-313
Year: 2007



Nebulised colistin for ventilator-associated pneumonia prevention
Source: Eur Respir J 2015; 46: 1732-1739
Year: 2015



Prevention of ventilator-associated pneumonia: possible role of antimicrobials administered via the respiratory tract
Source: Eur Respir J 2008; 31: 1138-1139
Year: 2008


How to prevent ventilator-associated pneumonia
Source: Annual Congress 2013 –PG3 Infections and critical patients: emerging problems and clinical strategies
Year: 2013



Inhaled antibiotics in ventilator-associated pneumonia: treatment or prophylaxis?
Source: International Congress 2016 – PG13 Inhaled antibiotics in respiratory infections
Year: 2016



Respiratory infections in the immunocompetent host: from asthma exacerbations to hospital-acquired pneumonia
Source: Annual Congress 2007 - Infections year in review
Year: 2007


Diagnosis and treatment of nosocomial pneumonia in ALI/ARDS patients
Source: Eur Respir J 2003; 22: 77S-83S
Year: 2003



The lung bacterial microbiome in community-acquired and nosocomial pneumonia
Source: Eur Respir Monogr 2019; 83: 188-194
Year: 2019


VAP prevention: pharmacological strategies
Source: Eur Respir Mon 2011; 53: 74-82
Year: 2011


Effects of antibiotics on protected specimen brush sampling in ventilator-associated pneumonia
Source: Eur Respir J 2002; 19: 944-951
Year: 2002



Preventing ventilator-associated pneumonia
Source: International Congress 2017 – PG12 Life-threatening pulmonary infections
Year: 2017


Pharmacokinetic optimisation of β-lactams for the treatment of ventilator-associated pneumonia
Source: Eur Respir Rev 2007; 16: 45-49
Year: 2007



Determinants of prescription and choice of empirical therapy for hospital-acquired and ventilator-associated pneumonia
Source: Eur Respir J 2011; 37: 1332-1339
Year: 2011



Challenges in the management of hospital-acquired pneumonia including ventilator-associated pneumonia
Source: ERS Course 2018 - Respiratory Infections
Year: 2018

Are corticosteroids useful in community-acquired pneumonia?
Source: Annual Congress 2006 - Evaluation of risk factors in community-acquired pneumonia
Year: 2006


Lower respiratory tract infections: when are antibiotics mandatory?
Source: ISSN=1025-448x, ISBN=1-904097-32-4, page=146
Year: 2004

Microbial investigation in ventilator-associated pneumonia
Source: Eur Respir J 2001; 17: 791-801
Year: 2001



Reducing antibiotics use for ventilator-associated pneumonia in brain-injured patients
Source: Eur Respir J 2016; 47: 1060-1061
Year: 2016


Is ventilated hospital-acquired pneumonia a worse entity than ventilator-associated pneumonia?
Source: Eur Respir Rev, 29 (157) 200023; 10.1183/16000617.0023-2020
Year: 2020



What is pneumonia?
Source: Breathe, 17 (3) 210087; 10.1183/20734735.0087-2021
Year: 2021